These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation. Müller-Lissner S; Holtmann G; Rueegg P; Weidinger G; Löffler H Aliment Pharmacol Ther; 2005 Jan; 21(1):11-20. PubMed ID: 15644040 [TBL] [Abstract][Full Text] [Related]
23. Practitioners, patients, and their visits: a description of accident and medical (A&M) clinics in New Zealand, 2001/2. Hider P; Lay-Yee R; Davis P N Z Med J; 2007 May; 120(1254):U2538. PubMed ID: 17515942 [TBL] [Abstract][Full Text] [Related]
24. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Vandvik PO; Wilhelmsen I; Ihlebaek C; Farup PG Aliment Pharmacol Ther; 2004 Nov; 20(10):1195-203. PubMed ID: 15569123 [TBL] [Abstract][Full Text] [Related]
25. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Ford AC; Forman D; Bailey AG; Axon AT; Moayyedi P Am J Gastroenterol; 2008 May; 103(5):1229-39; quiz 1240. PubMed ID: 18371141 [TBL] [Abstract][Full Text] [Related]
26. Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial. Roberts L; Wilson S; Singh S; Roalfe A; Greenfield S Br J Gen Pract; 2006 Feb; 56(523):115-21. PubMed ID: 16464325 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis and care of irritable bowel syndrome in a community-based population. Yawn BP; Locke GR; Lydick E; Wollan PC; Bertram SL; Kurland MJ Am J Manag Care; 2001 Jun; 7(6):585-92. PubMed ID: 11439732 [TBL] [Abstract][Full Text] [Related]
28. Women with irritable bowel syndrome and their perception of a good quality of life. Bengtsson M; Ohlsson B; Ulander K Gastroenterol Nurs; 2007; 30(2):74-82. PubMed ID: 17440306 [TBL] [Abstract][Full Text] [Related]
29. Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome. van der Veek PP; van Rood YR; Masclee AA Aliment Pharmacol Ther; 2007 Sep; 26(6):943-52. PubMed ID: 17767479 [TBL] [Abstract][Full Text] [Related]
30. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome? Sperber AD; Shvartzman P; Friger M; Fich A Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):441-7. PubMed ID: 17489053 [TBL] [Abstract][Full Text] [Related]
31. Patients who do not receive continuity of care from their general practitioner--are they a vulnerable group? Sweeney KG; Gray DP Br J Gen Pract; 1995 Mar; 45(392):133-5. PubMed ID: 7772390 [TBL] [Abstract][Full Text] [Related]
32. The effects of exercise upon symptoms and quality of life in patients diagnosed with irritable bowel syndrome: a randomised controlled trial. Daley AJ; Grimmett C; Roberts L; Wilson S; Fatek M; Roalfe A; Singh S Int J Sports Med; 2008 Sep; 29(9):778-82. PubMed ID: 18461499 [TBL] [Abstract][Full Text] [Related]
33. Gastro-oesophageal reflux disease and irritable bowel syndrome: a significant association in an Iranian population. Solhpour A; Pourhoseingholi MA; Soltani F; Zarghi A; Solhpour A; Habibi M; Zali MR Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):719-25. PubMed ID: 18617775 [TBL] [Abstract][Full Text] [Related]
34. Irritable bowel syndrome and the Rome III criteria: for better or for worse? Gwee KA Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):437-9. PubMed ID: 17489052 [TBL] [Abstract][Full Text] [Related]
35. A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome. Robinson A; Lee V; Kennedy A; Middleton L; Rogers A; Thompson DG; Reeves D Gut; 2006 May; 55(5):643-8. PubMed ID: 16099784 [TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Törnblom H; Holmvall P; Svenungsson B; Lindberg G Clin Gastroenterol Hepatol; 2007 Apr; 5(4):461-4. PubMed ID: 17445752 [TBL] [Abstract][Full Text] [Related]
37. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients. Mearin F; Badía X; Balboa A; Benavent J; Caballero AM; Domínguez-Muñoz E; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M; Aliment Pharmacol Ther; 2006 Mar; 23(6):815-26. PubMed ID: 16556184 [TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129 [TBL] [Abstract][Full Text] [Related]
39. Utilisation of health care by women who have suffered abuse: a descriptive study on medical records in family practice. Lo Fo Wong S; Wester F; Mol S; Römkens R; Lagro-Janssen T Br J Gen Pract; 2007 May; 57(538):396-400. PubMed ID: 17504591 [TBL] [Abstract][Full Text] [Related]
40. Chronic non-specific abdominal complaints in general practice: a prospective study on management, patient health status and course of complaints. van den Heuvel-Janssen HA; Borghouts JA; Muris JW; Koes BW; Bouter LM; Knottnerus JA BMC Fam Pract; 2006 Mar; 7():12. PubMed ID: 16512926 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]